BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 33989265)

  • 1. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.
    Creel-Bulos C; Sniecinski R
    Shock; 2021 Jun; 55(6):845-846. PubMed ID: 33989265
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer.
    Lisman T
    Shock; 2021 Jun; 55(6):844-845. PubMed ID: 33989264
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolysis Shutdown in Severe COVID-19: Highly Prevalent but not Independently Predictive of Thrombosis or Poorer Outcomes.
    Littlejohn J; Vasovic LV; Cushing MM; Barie PS
    J Am Coll Surg; 2022 Jan; 234(1):97-98. PubMed ID: 35213468
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis Shutdown in COVID-19-Infected Patients Can Result from Iron-Induced Stabilization of Fibril Clots.
    Sukhomlin T
    J Am Coll Surg; 2020 Nov; 231(5):607-608. PubMed ID: 32972832
    [No Abstract]   [Full Text] [Related]  

  • 5. Beware overestimation of thrombosis in ICU: Mortality is not the only competing risk!
    Borjas-Howard JF; Bhoelan S; van Miert J; Eck R; Kooistra HAM; Meijer K; Tichelaar VYIG
    Thromb Res; 2020 Sep; 193():78. PubMed ID: 32526544
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data].
    Zerwes S; Hernandez Cancino F; Liebetrau D; Gosslau Y; Warm T; Märkl B; Hyhlik-Dürr A
    Chirurg; 2020 Jul; 91(7):588-594. PubMed ID: 32504106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery.
    Walsh MM; Khan R; Kwaan HC; Neal MD
    J Am Coll Surg; 2021 Jun; 232(6):1003-1006. PubMed ID: 33839011
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.
    Weiss E; Roux O; Moyer JD; Paugam-Burtz C; Boudaoud L; Ajzenberg N; Faille D; de Raucourt E
    Thromb Haemost; 2020 Sep; 120(9):1343-1345. PubMed ID: 32645725
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.
    Barral M; Arrive L; El Mouhadi-Barnier S; Cornelis FH
    Intensive Care Med; 2021 Sep; 47(9):1034-1036. PubMed ID: 34132839
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of SARS-CoV-2 Decontamination and Containment in a COVID-19 ICU.
    Brune Z; Kuschner CE; Mootz J; Davidson KW; Pena RCF; Ghanem MH; Fischer A; Gitman M; Teperman L; Mason C; Becker LB
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33802332
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series.
    Duque P; Chasco-Ganuza M; Burgos-Santamaria A; Terradillos E
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):298-301. PubMed ID: 33491994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe arterial thrombosis associated with Covid-19 infection.
    Kashi M; Jacquin A; Dakhil B; Zaimi R; Mahé E; Tella E; Bagan P
    Thromb Res; 2020 Aug; 192():75-77. PubMed ID: 32425264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 associated pulmonary thrombosis.
    van Nieuwkoop C
    Thromb Res; 2020 Jul; 191():151. PubMed ID: 32386985
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombosis and COVID-19 pneumonia: the clot thickens!
    Price LC; McCabe C; Garfield B; Wort SJ
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32554532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
    Nielsen ND; Rollins-Raval MA; Raval JS; Thachil J
    Thromb Res; 2022 Feb; 210():1-3. PubMed ID: 34953317
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 mortality and ICU admission: the Italian experience.
    Immovilli P; Morelli N; Antonucci E; Radaelli G; Barbera M; Guidetti D
    Crit Care; 2020 May; 24(1):228. PubMed ID: 32414403
    [No Abstract]   [Full Text] [Related]  

  • 17. ICU admission and outcome of patients with COVID-19: Does ICU stay improve survival?
    Shoar S
    Heart Lung; 2021; 50(3):470. PubMed ID: 33526284
    [No Abstract]   [Full Text] [Related]  

  • 18. Germany's next shutdown-Possible scenarios and outcomes.
    Barbarossa MV; Fuhrmann J
    Influenza Other Respir Viruses; 2021 May; 15(3):326-330. PubMed ID: 33277962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surging ICU capacity during the COVID-19 pandemic: Experiences from transforming a Post Anaesthesia Care Unit into a cohort ICU.
    Kersten BJ; Salden RLTN; van Klei WA; Hoff RG; Schellekens WM
    J Clin Anesth; 2020 Dec; 67():110036. PubMed ID: 32919255
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit.
    Vlot EA; Van den Dool EJ; Hackeng CM; Sohne M; Noordzij PG; Van Dongen EPA
    Thromb Res; 2020 Dec; 196():1-3. PubMed ID: 32805623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.